2005
DOI: 10.1111/j.1526-4610.2005.05163.x
|View full text |Cite
|
Sign up to set email alerts
|

The Quality of Headache Treatment in The United States: Review and Analysis of Recent Data

Abstract: The methods and results of a recent large study of the quality of health care in the United States are reviewed with special emphasis on findings specific to headache care. The study's implications for educational and quality improvement efforts in the headache field are considered. These include (i) the need to teach and reinforce fundamental history-taking and physical-examination processes at all levels of medical education; (ii) the importance of recognizing serious problems of underuse and misuse of prove… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 13 publications
0
6
0
Order By: Relevance
“…2,3 Guideline discordant neuroimaging overuse appears to be common for headache 4,5 and peripheral neuropathy. [6][7][8] At the same time, underuse of neuroimaging in some highrisk headache patients 9 and diagnostic laboratory testing 10 in neuropathy patients likely exists. 6 The Veterans Affairs (VA) health system is a single-payer health system that is largely separate from the private sector health care system.…”
mentioning
confidence: 99%
“…2,3 Guideline discordant neuroimaging overuse appears to be common for headache 4,5 and peripheral neuropathy. [6][7][8] At the same time, underuse of neuroimaging in some highrisk headache patients 9 and diagnostic laboratory testing 10 in neuropathy patients likely exists. 6 The Veterans Affairs (VA) health system is a single-payer health system that is largely separate from the private sector health care system.…”
mentioning
confidence: 99%
“…This is apparent when one recognizes that triptans, while considered the "gold standard" of migraine treatment, are not increasing in utilization by the migraine population. 16,17 Reality dictates that patients are seeking more than triptans alone provide. Understanding this "adherence gap" represents the distance between evidence-based medicine and patient-centered care.…”
Section: Discussionmentioning
confidence: 99%
“…The care that headache sufferers receive is generally poor and <50% of patients are satisfied with their current treatment (1–3). To date, the primary research focus has been on the epidemiology, pathophysiology and treatment of headache.…”
Section: Introductionmentioning
confidence: 99%